MARYROSE KEENAN: Open Payments
NPI 1326710310 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 17 payments from 9 companies in 2025. Trend: 2023 $482 · 2024 $680 · 2025 $474
Food & beverage: $313Education: $161
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 4 | $216 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $61 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| BridgeBio Pharma, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Amgen Inc. | 1 | $18 |
| Edwards Lifesciences Corporation | 1 | $17 |
Products named: OPSUMIT, CAMZYOS, LifeVest, UPTRAVI, VERQUVO, Attruby, LEQVIO, LOKELMA.
Industry payments across NY — which companies pay providers there.
